|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 22, 2016 ) About Myelodysplastic Syndrome
Myelodysplastic syndrome is a group of hematologic disorders that arise in the bone marrow and spread into the blood.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=527262
The syndrome is characterized by the inability of the hematopoietic cells produced in the bone marrow to attain maturity. Cytological dysplasia is a common feature of the syndrome, progressing to acute myeloid leukemia in about 30% of individuals with Myelodysplastic Syndrome. The disease is age-related, mostly affecting people aged 60 and above. Smoking, exposure to radiation, contact with chemicals such as benzene, genetic mutations, and chemotherapy can cause myelodysplastic syndrome.
Technavios analysts forecast the global myelodysplastic syndrome market to grow at a CAGR of 9.93% during the period 2015-2019.
Covered in this report
The report covers the present scenario and the growth prospects of the global myelodysplastic syndrome market for 2015-2019. To calculate the market size, we consider revenue generated from the sales of various drugs used for treating myelodysplastic syndrome.
The report describes the market by region:
Americas: The US, Canada, Mexico, and Brazil
EMEA: The UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE
APAC: Japan, China, Australia, Singapore, South Korea, and India
Technavio's report, Global Myelodysplastic Syndrome Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Celgene
Novartis
Otsuka
Other prominent vendors
Acceleron Pharma
Amgen
Astellas
Astex
Actinium Pharmaceuticals
Bellicum Pharmaceuticals
BioLineRx
Celator Pharmaceuticals
Cornerstone Pharmaceuticals
CTI BioPharma
Eli Lilly
Gamida Cell
Browse Detail Report With TOC @ http://www.researchmoz.us/global-myelodysplastic-syndrome-market-2015-2019-report.html
GlaxoSmithKline
KaloBios Pharmaceuticals
Kiadis Pharma
Mirati Therapeutics
Onconova Therapeutics
Strategia Therapeutics
Sumitomo Dainippon Pharma
Sunesis Pharmaceuticals
Targazyme
TetraLogic Pharmaceuticals
Market driver
Rise in aging population
For a full, detailed list, view our report
Market challenge
Use of off-label drugs
For a full, detailed list, view our report
Market trend
Rise in public awareness
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=527262
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
